Security Snapshot

MIMEDX GROUP, INC. - Common Stock, Par Value of $0.001 Per Share (MDXG) Institutional Ownership

CUSIP: 602496101

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

232

Shares (Excl. Options)

112,771,769

Price

$3.95

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, Par Value of $0.001 Per Share
Symbol
MDXG on Nasdaq
Shares outstanding
146,747,238
Price per share
$3.09
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
112,771,769
Total reported value
$445,448,865
% of total 13F portfolios
0%
Share change
+5,839,620
Value change
+$17,294,540
Number of holders
232
Price from insider filings
$3.09
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • MDXG - MIMEDX GROUP, INC. - Common Stock, Par Value of $0.001 Per Share is tracked under CUSIP 602496101.
  • 232 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 231 to 232 between Q4 2025 and Q1 2026.
  • Reported value moved from $724,484,940 to $445,448,865.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 232 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 602496101?
CUSIP 602496101 identifies MDXG - MIMEDX GROUP, INC. - Common Stock, Par Value of $0.001 Per Share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of MIMEDX GROUP, INC. - Common Stock, Par Value of $0.001 Per Share (MDXG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Trigran Investments, Inc. 4.2% $39,692,193 6,163,384 Trigran Investments, Inc. 31 Dec 2025

As of 31 Mar 2026, 232 institutional investors reported holding 112,771,769 shares of MIMEDX GROUP, INC. - Common Stock, Par Value of $0.001 Per Share (MDXG). This represents 77% of the company’s total 146,747,238 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of MIMEDX GROUP, INC. - Common Stock, Par Value of $0.001 Per Share (MDXG) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Essex Woodlands Management, Inc. 19% 28,195,249 0% 44% $111,371,234
BlackRock, Inc. 8.1% 11,911,300 +5.1% 0% $47,049,635
Trigran Investments, Inc. 4.9% 7,175,109 +16% 6.8% $28,341,680
VANGUARD CAPITAL MANAGEMENT LLC 3.5% 5,166,006 0% 0% $20,405,724
STATE STREET CORP 3.4% 5,056,801 +33% 0% $19,974,364
PARADIGM CAPITAL MANAGEMENT INC/NY 2.3% 3,410,300 +39% 0.52% $13,470,685
Nantahala Capital Management, LLC 2.3% 3,397,299 +41% 0.84% $13,419,331
RENAISSANCE TECHNOLOGIES LLC 2.1% 3,019,871 +22% 0.02% $11,928,490
GEODE CAPITAL MANAGEMENT, LLC 2% 2,881,159 +1.4% 0% $11,382,474
First Light Asset Management, LLC 1.9% 2,842,892 -6.5% 1% $11,229,423
DIMENSIONAL FUND ADVISORS LP 1.8% 2,694,002 +8.7% 0% $10,640,482
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1.4% 2,019,718 +0.62% 0.46% $7,977,886
MARSHALL WACE, LLP 1.3% 1,861,146 +35% 0.01% $7,351,527
Qube Research & Technologies Ltd 1.1% 1,651,519 +20% 0.01% $6,523,500
CANNELL CAPITAL LLC 1% 1,497,186 +1.7% 3.8% $5,913,885
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.94% 1,379,165 +13% 0% $5,447,702
GOLDMAN SACHS GROUP INC 0.81% 1,185,561 +8.7% 0% $4,682,966
VANGUARD PORTFOLIO MANAGEMENT LLC 0.75% 1,105,718 0% 0% $4,367,586
Meros Investment Management, LP 0.74% 1,093,028 -18% 1.9% $4,317,461
DEUTSCHE BANK AG\ 0.71% 1,035,030 +709% 0% $4,088,369
NORTHERN TRUST CORP 0.7% 1,023,106 +0.7% 0% $4,041,269
AQR CAPITAL MANAGEMENT LLC 0.62% 912,728 +124% 0% $3,605,275
VANGUARD FIDUCIARY TRUST CO 0.56% 822,969 0% 0% $3,250,728
MORGAN STANLEY 0.55% 812,742 +12% 0% $3,210,331
CITADEL ADVISORS LLC 0.53% 776,441 +73% 0% $3,066,942

Institutional Holders of MIMEDX GROUP, INC. - Common Stock, Par Value of $0.001 Per Share (MDXG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 112,771,769 $445,448,865 +$17,294,540 $3.95 232
2025 Q4 107,011,619 $724,484,940 +$16,262,521 $6.77 231
2025 Q3 104,565,923 $729,806,385 +$3,770,122 $6.98 228
2025 Q2 104,177,775 $636,523,946 +$13,614,767 $6.11 219
2025 Q1 101,678,894 $772,750,836 +$2,250,935 $7.60 216
2024 Q4 101,024,438 $971,759,022 +$30,075,358 $9.62 211
2024 Q3 98,110,776 $579,826,608 +$16,052,758 $5.91 191
2024 Q2 94,857,325 $657,434,813 +$8,061,306 $6.93 202
2024 Q1 93,588,264 $720,625,474 +$46,211,230 $7.70 201
2023 Q4 88,079,127 $772,431,392 +$270,474,988 $8.77 199
2023 Q3 56,937,901 $414,656,007 +$43,896,497 $7.29 185
2023 Q2 50,887,547 $336,810,580 -$33,204,488 $6.61 174
2023 Q1 68,294,535 $232,872,391 +$8,938,034 $3.41 159
2022 Q4 66,083,704 $183,706,622 +$4,774,267 $2.78 150
2022 Q3 64,383,251 $184,771,560 +$8,116,561 $2.87 140
2022 Q2 61,553,100 $213,579,735 +$59,259 $3.47 146
2022 Q1 61,550,830 $289,837,859 +$8,176,629 $4.71 147
2021 Q4 59,513,973 $359,751,969 +$4,148,643 $6.04 148
2021 Q3 54,147,913 $328,183,125 -$23,628,969 $6.06 140
2021 Q2 56,950,177 $712,436,791 +$126,800,548 $12.51 137
2021 Q1 47,290,218 $487,049,768 +$71,861,998 $10.30 110
2020 Q4 40,398,385 $367,588,663 +$326,323,820 $9.08 105
2020 Q3 4,484,161 $28,496,607 +$67,486 $6.35 20
2020 Q2 4,473,526 $24,153,915 -$282,981 $5.40 19
2020 Q1 4,102,881 $14,323,530 -$417,956 $3.49 19
2019 Q4 4,198,415 $31,809,496 -$2,251,353 $7.58 18
2019 Q3 4,511,760 $22,108,553 +$14,860,235 $4.90 18
2019 Q2 1,481,376 $5,998,936 -$400,357 $4.05 15
2019 Q1 1,582,769 $5,553,545 -$11,871,790 $3.51 16
2018 Q4 8,598,974 $15,378,561 -$436,052,423 $1.79 35
2018 Q3 76,501,479 $472,618,496 -$2,487,165 $6.18 180
2018 Q2 76,663,241 $489,857,907 -$63,696,098 $6.39 203
2018 Q1 86,558,341 $603,362,226 -$75,986,412 $6.97 216
2017 Q4 89,543,010 $1,129,484,861 +$133,324,998 $12.61 229
2017 Q3 77,615,476 $922,118,014 +$134,069,633 $11.88 227
2017 Q2 67,924,439 $1,016,774,723 +$116,684,634 $14.97 207
2017 Q1 61,910,052 $590,211,984 +$147,671,021 $9.53 172
2016 Q4 55,944,605 $495,664,784 +$16,208,762 $8.86 179
2016 Q3 56,056,379 $480,745,201 +$61,023,299 $8.58 176
2016 Q2 48,996,432 $390,927,340 +$24,525,003 $7.98 180
2016 Q1 45,698,645 $399,275,804 -$2,049,611 $8.74 187
2015 Q4 45,761,908 $428,717,013 -$46,277,791 $9.37 182
2015 Q3 49,722,558 $479,820,758 -$28,205,196 $9.65 176
2015 Q2 51,355,867 $595,168,690 +$97,747,717 $11.59 167
2015 Q1 43,472,054 $451,239,752 +$28,369,352 $10.40 144
2014 Q4 40,235,888 $463,507,830 +$5,885,238 $11.53 140
2014 Q3 39,329,149 $280,319,261 +$298,210 $7.13 123
2014 Q2 39,304,250 $278,130,134 +$35,581,703 $7.09 128
2014 Q1 33,574,183 $205,790,565 +$16,972,736 $6.13 107
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .